Viv BioTech

Li

www
n

ited

ivobio.com
for zero disease

Date: 77/08/2076
To

Deputy Manager
Dept. of Corporate Services,
Bombay Stock Exchange Limited
P J Towers, Dalal Street,
Fort, MUMBAI - 400001
Dear Sir/Madam,
Sub: Unaudited financial results for the quarter ended on ?Oth June,

Ref: Reg. 33 of SEBI(Listing obligations

and Disclosure Requirem

Regulation s, 2015 Agreement, Script Code# 511509

With reference to subject cited above please find enclosed Unaudited fina ial results
for the quarter the quarter ended on 30th June , 2076 as per the Reg.33 of BI (Listing
Obligations and Disclosure Requirements) Regulations, 2015 along w th Limited
Review Report issued by the Statutory Auditors of the company
This is for your record and reference,

Thanking you,
Yours faithfully,
For Vivo

HYderabao

M Kaly
Whole Ti
DIN:02012580

Sy. No : 349/A, 350/A, 351, 356/34

(SEZ-special Economic Zone)

Village: Pregnapur,
Gajwel Mandal, Medak District,
Andhra Pradesh. IND|A

Lingapur
Ph. : +91

cSlc so: i5

# 608. 6th Floor,

Himayat Nagar,
- 500 029. A.P., INDIA

667U714,66784719
Fax: +914066776112

qq3lGlqffi&ooats

Vivror BioTerch
mit)
www.vivobio.com
n
Unaudited Financi:l Flacr,trc fa
S.No.

Hso,

QUARTER ENDE[I

Income from Ooerati

a) Net Sales/ Income from Operatbrs

-:-_
b)otheroperatiffiTotal IncomefromnF
1
L

Expenses

a.tncrease/(decffi
b, Constrmnti^.
^ffi
c Prtrrheco
nf
_,,_-v
Y, !r svrv

-_
. Depreciation

31,03.2016

Unaudited

Audited

Audited

6 Finance

623.32

735.09
0.00

0.00

6,43

818.19

735.09

605.22

2858.33

|Profit/(|oss)fromordinaryactiVitiesatte@
7 exceptiona I items(5-6)
8 Exceptional itu.t
9 Profit/t-oss
from O
-_
10 Tar E"pentE=_.11 Net
-_ Profit/Lost frorn Ot
I

t2
NetProfit/tnccfnrth6D^ri^.r/1a
a.r
t4 ____:__l:_::-:::_
reL voruc v| n).tul_gdcn,,
-Paicl tln Shrra r'13

Reserves Excluding Revaruation

15
16.

prevtous accouting vear

!arnins Po.

n"ffi

qh".o/roiil

l )Basic

r)Diluted

i6.ii
rJ

bastc

r)

Diluted

--

Date:11th August, 2016

605.22

122.40

s0.56

0.00

42.73

190.08

0.00
131.68

0.00
127.35

88.08

83.85

91.68

0.00
780.54

0.00
448.65
760.97

37.65

-25. 88

23.37

31.58

17.89

or.ul

5,69

s8.0c

L;24.6

9.63

15.54

9.60

,16.5

1.39

9.85

48.40

0,00

0.00
-9.85

0.00

0.00

48.40

iB ol

51.39
11 f,a

39.3

40.09

29.47

000
7

(SEZ-Special Economic Zone)

Village: Pregnapur,
Gajwel Mandal, Medak District,
Andhra Pradesh. INDIA

)t)
29

0.00
434.26

6.1.6

35.40

21_0.79

1t73.46

)o).11

2822.97

40.r1

35.36
89.2t;

)t8.04

14.52

12.96

33.88

91.00

0.00
3.88

0.00
91.00

0.00

0.00
29.47

935.05

935.05

935.05

935.05

0.00

0.00

0.00

0.00

0.43

0.32

0.36

t).9'/

0.43

0.32

0.36

0.97

0.43
0.43

0.32
0,32

0.36

0.97

0.36

Q9/

,@ :';;*n:ulon,",

Sy. No : 349/A, 350/A, 351, 356/3A

OU.

fi19

40.09

Place: Hyderabad

2t51.90

205.00

s vLrrEr rrLUrIte, lnance cost and

costs

trnaudited

r94.87

ZJ/,OI

)rofit/losc frnm f)no,

exceptions items(1-2) Other income
Profit/(loss) fror OrOit
exceptional items(3+4)

YEAR INDED

31.03.2016 3Cr.06.2015

Other Expenditure
.Adminictr:tirro Fwn

- Total

ln Lakhs

30.06.2016

6vvuJ

Emolovcecl^nct

Rs.

rsr EIueu on 5ulvo/ zul6

PARTICUTARS

proteins for zero disease

".

Li

m i t,, d

9_{inro"''u"-'F};n-t
a"^
K\*-l\
.......=-ffixyetva,

---'

---.DtN,

ozortffi$, 6th Floor,

Lingapur Complex, HimaYat Nagar,
Hyderabrad - 500 029. A.P., INDIA
Ph. : +91 (.t0) 667847 14, 667 847'19
Fax : +91-40-661'76112

gqqS'ic't t98n8ffi16=
c$N tt o: 1.,6

Viv BioTech
ited

Li

www

ivobio.com
for zero dispase

n
Notes:

t.

The above financial results are recommended by the Audit Committee were

sidered and

approved by the board of directors at their meeting held on 11'n August, 201
2.

In

accordance

with the Regulation 33 of the

SEBI (Listing and

Disclosure

Requirements) Regulations, 2015, Statutory Auditors have performed limit

review of the

financial results of M/s. Vivo Bio Tech Limited for the quarter ended 30th

Ju

,2016. There

Bio Tec

gy. Hence

are no qualifications in the limited review report issued for the said period
3.

fhe Entire operations of the company relate to single segment viz.,

Segrnental reporting.as perAS-17 is not made.

4.

Previous year's/period's figures are rearranged/ regrouped wherever neces

Date:1Lrth August, 2016

Place: Hyderabad

Bio Tech Limited

n
o

(i)

Ram

Time Director
DIN:02012580

# 608, 6tir Floor,

nplex, Himayat Nagar,
- 500 029. A.P.r INDIA

Sy. No : 349/A, 3$0/A, 351, 356/34

(SEZ-Special E@nomic Zone)

Mllage : Pregnapqtr,

66784714,66784719

Gajwel Mandal, Medak District,

Andhra Pradesh.INDIA

Fax: +91406T76112

CtN

rilo:

;Sqqstq\q8+?tcod+/61

P. MURALI9
& CO

CHARTERED ACCOUNTANTS
6-3-655/2/3, SOMAJIGUDA,
HYDERABAD - 500 082. INDIA -

Limited Review Report

Tel.
Fax

: (91-40) 2332 6666, 2331 2554

2339 3967, 2332 1470
: (91-40) 2339 2474

E-mail : pmurali.co@gmail.com
info@pmurali.com
Website : www.pmurali.com

To
The Board of Directors
Vivo Bio Tech Limited
Hyderabad.
Limited Review Report for the quarter ended 30th June, 2016.
We have reviewed the accompanying Statement of Unaudited Financial Results of
Vivo Bio Tech Limited for the Period/Quarter I Ended 30th June 2016. This Statement is the
responsibility of the Company's Management and has been approved by the Board of Directors.
Our responsibility is to issue a report on these financial statements based on our review.
We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410,
Review of interim financial information performed by the independent auditor of the entity
issued by the Institute of Chartered Accountants of India. This standard requires that we plan
and perform the review to obtain moderate assurance as to whether the financial statements are
free of material misstatement. A. review is limited primarily to inquiries of company personnel
and analytical procedures applied to financial data and thus provide less assurance than an
audit. We have not performed an audit and accordingly, we do not express an audit opinion.
Based on our review conducted as above, nothing has come to our attention that causes us to
believe that the accompanying statement of Unaudited Financial Results prepared in
accordance with applicable accounting standards and other recognized accounting practices
and policies has not disclosed the information required to be disclosed in terms of Regulation 33
of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the
manner in which it is to be disclosed, or that it contains any material misstatement.
For P. Murali & Co.,
Chartered Accountants
Firm Registration No : 007257S

A. Krishna Rao
Partner
Membership No. 020085
Place: Hyderabad
Date: 11/08/2016